Alaunos Therapeutics, Inc. (TCRT)

NASDAQ: TCRT · IEX Real-Time Price · USD

0.630

-0.021 (-3.21%)

At close: Jul 2, 2024, 4:00 PM

0.657

+0.027 (4.30%)

After-hours: Jul 2, 2024, 6:22 PM EDT

Alaunos Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018 - 2005
Market Capitalization	10	17	140	236	540	854	Upgrade
Market Cap Growth	-80.85%	-87.88%	-40.44%	-56.37%	-36.80%	220.92%	Upgrade
Enterprise Value	6	11	107	189	429	776	Upgrade
PE Ratio	-	-0.48	-3.72	-2.99	-6.75	-7.25	Upgrade
PS Ratio	2017.90	3402.47	48.02	591.96	-	-	Upgrade
PB Ratio	2.10	2.70	3.64	4.06	4.36	8.99	Upgrade
P/FCF Ratio	-1.36	-0.59	-4.77	-3.64	-8.09	-20.77	Upgrade
P/OCF Ratio	-1.28	-0.56	-4.80	-3.83	-9.47	-20.92	Upgrade
EV/Sales Ratio	1188.90	2190.07	36.55	474.54	-	-	Upgrade
EV/EBITDA Ratio	-1.04	-0.36	-3.41	-2.51	-5.44	-6.62	Upgrade
EV/EBIT Ratio	-0.97	-0.33	-3.09	-2.44	-5.36	-6.59	Upgrade
EV/FCF Ratio	-1.17	-0.38	-3.63	-2.92	-6.42	-18.87	Upgrade
Debt / Equity Ratio	-	-	0.51	0.51	0.03	0.02	Upgrade
Debt / EBITDA Ratio	-	-	-0.62	-0.39	-0.05	-0.01	Upgrade
Debt / FCF Ratio	-	-	-0.66	-0.45	-0.06	-0.04	Upgrade
Quick Ratio	3.34	3.10	2.19	4.81	6.53	6.64	Upgrade
Current Ratio	4.87	4.22	2.23	4.91	7.11	8.42	Upgrade
Asset Turnover	0	0	0.04	0.00	0	0	Upgrade
Interest Coverage	-24.07	-17.29	-10.96	-65.23	-	-	Upgrade
Return on Equity (ROE)	-229.60%	-197.00%	-94.30%	-98.20%	-52.20%	-139.70%	Upgrade
Return on Assets (ROA)	-173.70%	-134.80%	-51.80%	-71.00%	-46.20%	-122.80%	Upgrade
Return on Capital (ROIC)	-549.05%	-543.32%	-60.46%	-88.71%	-62.79%	-59.90%	Upgrade
Earnings Yield	-265.37%	-206.56%	-26.89%	-33.43%	-14.81%	-13.79%	Upgrade
FCF Yield	-211.20%	-169.27%	-20.97%	-27.50%	-12.37%	-4.81%	Upgrade
Buyback Yield / Dilution	-0.21%	-10.50%	-1.27%	-2.27%	-24.82%	-16.87%	Upgrade
Total Shareholder Return	-0.21%	-10.50%	-1.27%	-2.27%	-24.82%	-16.87%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).